From a chemical point of view, CO₂ represents an easily accessible, non-toxic and cheap C1 building block with high synthetic potential, and thus many efforts are devoted to the valorization of this carbon feedstock. In view of the growing public awareness on the importance of sustainability and green chemistry, research to capture CO₂ and to convert it into valuable chemicals deserves high priority. However, the development of energy-efficient methodologies for CO₂ fixation presents a major challenge, as most of the existing techniques suffer from a high-energy consumption. The deployment of small-ring substrates provides interesting opportunities in that respect, because their high ring strain energy allows for smooth transformations under mild reaction conditions. In addition, given the fact that 85% of FDA-approved drugs contains nitrogen in their structure, the pharmaceutical industry is in continuous demand for new nitrogen building blocks. In particular, there is a high need for fluorinated nitrogen compounds in the framework of drug development programs. In order to address these pertinent challenges, this project will investigate the eligibility of small-ring azaheterocycles for CO₂ capture to conveniently produce fluorinated cyclic carbamates as relevant building blocks for e.g. antibiotic development.